ARK Genomic Revolution ETF Sees Unusually High Options Volume (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the recipient of some unusual options trading activity on Monday. Traders acquired 27,609 call options on the stock. This represents an increase of approximately 155% compared to the typical daily volume of 10,820 call options.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

Large investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of ARK Genomic Revolution ETF by 30.6% in the 4th quarter. JPMorgan Chase & Co. now owns 5,149,454 shares of the company’s stock worth $149,180,000 after purchasing an additional 1,205,541 shares in the last quarter. Morgan Stanley raised its holdings in shares of ARK Genomic Revolution ETF by 42.2% during the 4th quarter. Morgan Stanley now owns 4,025,965 shares of the company’s stock valued at $116,632,000 after buying an additional 1,193,795 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of ARK Genomic Revolution ETF by 49.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,514,980 shares of the company’s stock valued at $101,829,000 after buying an additional 1,167,558 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of ARK Genomic Revolution ETF by 29.1% during the 4th quarter. Wells Fargo & Company MN now owns 1,287,390 shares of the company’s stock valued at $37,296,000 after buying an additional 290,301 shares in the last quarter. Finally, Royal Bank of Canada lifted its position in ARK Genomic Revolution ETF by 185.0% in the 4th quarter. Royal Bank of Canada now owns 445,592 shares of the company’s stock worth $12,910,000 after buying an additional 289,237 shares during the last quarter.

ARK Genomic Revolution ETF Stock Down 0.7%

BATS ARKG opened at $42.06 on Wednesday. ARK Genomic Revolution ETF has a 52-week low of $22.73 and a 52-week high of $42.70. The company has a fifty day moving average of $32.86 and a 200-day moving average of $30.49.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.